US2016166533A1PendingUtilityA1
Synergistic compositions and methods for potentiating anti-oxidative activity
Est. expiryJan 24, 2023(expired)· nominal 20-yr term from priority
A61P 43/00A61K 31/341A61K 31/00A61K 33/10A61K 33/08A61K 33/06A61K 45/06A61P 39/06
36
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to synergistic compositions for protection against oxidative damage, consisting essentially of antacids in conjunction with antioxidants. The invention further relates to method for preventing oxidative damage using the compositions of the invention.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A composition comprising:
(a) at least one antacid; (b) at least one antioxidant, wherein the relative amount of the at least one antioxidant in the composition is from 30 to 95% w/w of the composition; and, optionally, (c) at least one pharmaceutically acceptable carrier.
2 . The composition of claim 1 , being identified for use in protecting against excess gastric acidity.
3 . The composition according to claim 1 , wherein said at least one antacid comprises at least one classical antacid in a dose capable of neutralizing 100 ml of 0.009 M HCl, such that the composition is capable of elevating the pH in a stomach by at least one pH unit, said elevating the pH being from a pH of 2 to a pH of at least 3.
4 . The composition of claim 1 , wherein said at least one antacid comprises at least one classical antacid selected from a group consisting of sodium bicarbonate, potassium hydroxide, aluminum carbonate, aluminum hydroxide, aluminum phosphate, aluminum hydroxycarbonate, dihydroxy aluminum sodium carbonate, aluminum magnesium glycinate, dihydroxy aluminum aminoacetate, dihydroxyaluminum aminoacetic acid, calcium carbonate, calcium phosphate, hydrated magnesium aluminate activated sulfate, magnesium aluminate, magnesium aluminosilicates, magnesium carbonate, magnesium glycinate, magnesium hydroxide, magnesium oxide and magnesium trisilicate.
5 . The composition of claim 1 , wherein said at least one antacid comprises at least one H2-receptor antagonist and/or proton pump inhibitor.
6 . The composition of claim 1 , wherein the relative amount of said at least one antacid in the composition is from about 5 to about 90% w/w of the total antacid and antioxidant weight.
7 . The composition of claim 1 , wherein said antioxidant is a polyphenol.
8 . The composition of claim 7 , wherein said polyphenol is selected from the group consisting of chalcones, phenolic acid, anthocyanins, flavonols, flavanols, flavanones, flavanonols, hydrolyzed tannins, proanthocyanidins, phenolamines, lignans, lignine, betalains, stilbenes, cyclic diterpenes, monoterpenes, sesquiterpenes, sesamolin and isoflavones.
9 . The composition of claim 7 , wherein said polyphenol is selected from a group consisting of anthocyanins, flavonols, flavanols, flavanones, flavanonols, hydrolyzed tannins, proanthocyanidins, lignine, and stilbenes.
10 . A pharmaceutical composition, comprising:
(a) at least one pharmaceutically active ingredient; (b) at least one antacid; (c) at least one antioxidant, wherein the relative amount of the at least one antioxidant in the composition is from 30 to 95% w/w of the composition; and, optionally, (d) at least one pharmaceutically acceptable carrier, diluent or stabilizer.
11 . The composition according to claim 10 , wherein said at least one antacid comprises at least one classical antacid in a dose capable of neutralizing 100 ml of 0.009 M HCl, such that the composition is capable of elevating the pH in a stomach by at least one pH unit, said elevating the pH being from a pH of 2 to a pH of at least 3.
12 . The composition of claim 10 , wherein said at least one antacid comprises at least one classical antacid selected from a group consisting of sodium bicarbonate, potassium hydroxide, aluminum carbonate, aluminum hydroxide, aluminum phosphate, aluminum hydroxycarbonate, dihydroxy aluminum sodium carbonate, aluminum magnesium glycinate, dihydroxy aluminum aminoacetate, dihydroxyaluminum aminoacetic acid, calcium carbonate, calcium phosphate, hydrated magnesium aluminate activated sulfate, magnesium aluminate, magnesium aluminosilicates, magnesium carbonate, magnesium glycinate, magnesium hydroxide, magnesium oxide and magnesium trisilicate.
13 . The composition of claim 10 , wherein said at least one antacid comprises said at least one antacid comprises at least one H2-receptor antagonist and/or proton pump inhibitor.
14 . The composition of claim 10 , wherein the relative amount of said at least one antacid in the composition is from about 5 to about 90% w/w of the total antacid and antioxidant weight.
15 . The composition of claim 10 , wherein said antioxidant is a polyphenol.
16 . The composition of claim 15 , wherein the polyphenol is selected from the group consisting of chalcones, phenolic acid, anthocyanins, flavonols, flavanols, flavanones, flavanonols, hydrolyzed tannins, proanthocyanidins, phenolamines, lignans, lignine, betalains, stilbenes, cyclic diterpenes, monoterpenes, sesquiterpenes, sesamolin and isoflavones.
17 . The composition of claim 15 , wherein the polyphenol is selected from a group consisting of anthocyanins, flavonols, flavanols, flavanones, flavanonols, hydrolyzed tannins, proanthocyanidins, lignine, and stilbenes.
18 . A method for protecting a subject from oxidative damage, the method comprising administering to the subject a composition comprising:
(a) at least one antacid in a dose sufficient to elevate pH in a stomach; (b) at least one antioxidant in a dose sufficient to decrease free radical generation in the stomach; and, optionally (c) at least one carrier, diluent or stabilizer.
19 . The method of claim 18 , wherein said administering results in inhibition of peroxidation reactions in a gastrointestinal tract of the subject.
20 . The method of claim 18 , wherein said administering results in attenuation of generation of free radicals and/or peroxides in a gastrointestinal tract of the subject.
21 . The method of claim 18 , wherein said at least one antacid comprises at least one classical antacid in a dose capable of neutralizing 100 ml of 0.009 M HCl, such that the composition is capable of elevating the pH in a stomach by at least one pH unit, said elevating the pH being from a pH of 2 to a pH of at least 3.
22 . The method of claim 18 , wherein the composition is administered orally.
23 . The method of claim 18 , wherein the antacid comprises at least one classical antioxidant selected from the group consisting of sodium bicarbonate, potassium hydroxide, aluminum carbonate, aluminum hydroxide, aluminum phosphate, aluminum hydroxycarbonate, dihydroxy aluminum sodium carbonate, aluminum magnesium glycinate, dihydroxy aluminum aminoacetate, dihydroxyaluminum aminoacetic acid, calcium carbonate, calcium phosphate, hydrated magnesium aluminate activated sulfate, magnesium aluminate, magnesium aluminosilicates, magnesium carbonate, magnesium glycinate, magnesium hydroxide, magnesium oxide and magnesium trisilicate.
24 . The method of claim 18 , wherein said at least one the antacid comprises at least one antacid comprises at least one H2-receptor antagonist and/or proton pump inhibitor.
25 . The method of claim 18 , wherein the relative amount of the antacid in the composition is from about 5 to about 90% w/w of the total antacid and antioxidant weight.
26 . The method of claim 18 , wherein said antioxidant is a polyphenol, and the relative amount of said at least one antioxidant in the composition is from 30 to 95% w/w of the composition.
27 . The method of claim 18 , wherein said antioxidant is a polyphenol selected from the group consisting of chalcones, phenolic acid, anthocyanins, flavonols, flavanols, flavanones, flavanonols, hydrolyzed tannins, proanthocyanidins, phenolamines, lignans, lignine, betalains, stilbenes, cyclic diterpenes, monoterpenes, sesquiterpenes, sesamolin and isoflavones.
28 . A method for protecting a subject from excess gastric acidity, the method comprising administering to the subject a composition comprising:
(a) at least one antacid in a dose sufficient to elevate pH in a stomach; (b) at least one antioxidant in a dose sufficient to decrease free radical generation in the stomach; and, optionally (c) at least one carrier, diluent or stabilizer.
29 . The method of claim 28 , wherein said at least one antacid comprises at least one classical antacid in a dose capable of neutralizing 100 ml of 0.009 M HCl, such that the composition is capable of elevating the pH in a stomach by at least one pH unit, said elevating the pH being from a pH of 2 to a pH of at least 3.
30 . The method of claim 28 , wherein the antacid comprises at least one classical antioxidant selected from the group consisting of sodium bicarbonate, potassium hydroxide, aluminum carbonate, aluminum hydroxide, aluminum phosphate, aluminum hydroxycarbonate, dihydroxy aluminum sodium carbonate, aluminum magnesium glycinate, dihydroxy aluminum aminoacetate, dihydroxyaluminum aminoacetic acid, calcium carbonate, calcium phosphate, hydrated magnesium aluminate activated sulfate, magnesium aluminate, magnesium aluminosilicates, magnesium carbonate, magnesium glycinate, magnesium hydroxide, magnesium oxide and magnesium trisilicate.
31 . The method of claim 28 , wherein said at least one antacid comprises at least one H2-receptor antagonist and/or proton pump inhibitor.
32 . The method of claim 28 , wherein the relative amount of the antacid in the composition is from about 5 to about 90% w/w of the total antacid and antioxidant weight.
33 . The method of claim 28 , wherein said antioxidant is a polyphenol, and the relative amount of said at least one antioxidant in the composition is from 30 to 95% w/w of the composition.
34 . The method of claim 28 , wherein said antioxidant is a polyphenol selected from the group consisting of chalcones, phenolic acid, anthocyanins, flavonols, flavanols, flavanones, flavanonols, hydrolyzed tannins, proanthocyanidins, phenolamines, lignans, lignine, betalains, stilbenes, cyclic diterpenes, monoterpenes, sesquiterpenes, sesamolin and isoflavones.Join the waitlist — get patent alerts
Track US2016166533A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.